Funding for this research was provided by:
Tedec-Meiji Pharma S.A.
Text and Data Mining valid from 2018-11-02
Received: 21 May 2018
Accepted: 24 September 2018
First Online: 2 November 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable. All data included in the review is published and referenced.
: PRISM-AG SL have received grants from Tedec-Meiji Pharma S.A. (Madrid, Spain) for the performance of pharmacodynamic studies with cefditoren. MJG and LA are members of the Research Department of PRISM-AG.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.